nach oben

Erschienen in:

01.02.2011 | Original paper

Challenges in Addressing Depression in HIV Research: Assessment, Cultural Context, and Methods

Erschienen in: AIDS and Behavior | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Depression is one of the most common co-morbidities of HIV infection. It negatively impacts self-care, quality of life, and biomedical outcomes among people living with HIV (PLWH) and may interfere with their ability to benefit from health promotion interventions. State-of-the-science research among PLWH, therefore, must address depression. To guide researchers, we describe the main diagnostic, screening, and symptom-rating measures of depression, offering suggestions for selecting the most appropriate instrument. We also address cultural considerations in the assessment of depression among PLWH, emphasizing the need to consider measurement equivalence and offering strategies for developing measures that are valid cross-culturally. Finally, acknowledging the high prevalence of depression among PLWH, we provide guidance to researchers on incorporating depression into the theoretical framework of their studies and employing procedures that account for participants with depression.

Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.PubMedCrossRef

Valente SM. Depression and HIV disease. J Assoc Nurses AIDS Care. 2003;14(2):41–51.PubMedCrossRef

Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med. 2008;38(3):365–74.PubMedCrossRef

Safren S, Gonzalez J, Soroudi N. Coping with chronic illness: a cognitive-behavioral approach for adherence and depression. New York: Oxford University Press; 2007.

Kelley K, Bluthé R, Dantzer R, Zhou J, Shen W, Johnson R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17:62–72.CrossRef

Kopinsky K, Stoff D, Rausch D. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav Immun. 2004;18:246–61.CrossRef

Schroecksnadel K, Sarcletti M, Winkler C, Mumelter B, Weiss G, Fuchs D, et al. Quality of life and immune activation in patients with HIV-infection. Brain Behav Immun. 2008;22:881–9.PubMedCrossRef

Kalichman SC. Understanding AIDS: advances in research and treatment. Washington, DC: America Psychological Association; 1998.CrossRef

Gonzalez J, Hendriksen E, Collins E, Duran R, Safren S. Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav. 2009;13:582–602.PubMedCrossRef

10.

Mutchler M, Bogart L, Elliott M, McKay T, Suttorp M, Schuster M. Psychosocial correlates of unprotected sex without disclosure of HIV-positivity among African-American, Latino, and White men who have sex with men and women. Arch Sex Behav. 2008;37:736–47.PubMedCrossRef

11.

Simoni J, Demas P, Mason H, Drossman J, Davis M. HIV disclosure among women of African descent: associations with coping, social support, and psychological adaptation. AIDS Behav. 2000;4(2):147–58.CrossRef

12.

Rabkin J, McElhiney M, Ferrando S. Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS. 2004;18(Suppl 1):S43–8.PubMed

13.

CDC. HIV prevalence estimates-United States, 2006. Morb Mortal Wkly Rep. 2008;57:1073–6.

14.

Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163–71.PubMedCrossRef

15.

Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS. 2008;22(3):233–43.PubMedCrossRef

16.

Kacanek D, Jacobson D, Spiegelman D, Wanke C, Isaac R, Wilson I. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr. 2009; Epub ahead of print.

17.

Lima V, Geller J, Bangsberg D, Patterson T, Daniel M, Kerr T, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175–83.PubMedCrossRef

18.

Bolton JM, Robinson J, Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord. 2009;115(3):367–75.PubMedCrossRef

19.

Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, et al. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend. 2009;99(1–3):248–60.PubMedCrossRef

20.

Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21:14–8.PubMedCrossRef

21.

Dixit AR, Crum RM. Prospective study of depression and the risk of heavy alcohol use in women. Am J Psychiatry. 2000;157(5):751–8.PubMedCrossRef

22.

Kalichman SC, Kelly JA, Rompa D. Continued high-risk sex among HIV seropositive gay and bisexual men seeking HIV prevention services. Health Psychol. 1997;16(4):369–73.PubMedCrossRef

23.

Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573–80.PubMedCrossRef

24.

Keiser O, Spoerri A, Brinkhof M, Hasse B, Gayet-Ageron A, Tissot F, et al. Suicide in HIV-infected individuals and the general population in Switzerland, 1988–2008. Am J Psychiatry. 2010;167(2):143–50.PubMedCrossRef

25.

Kalichman S, Heckman T, Kochman A, Sikkema K, Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv. 2000;51(7):903–7.PubMedCrossRef

26.

Olatunji B, Mimiaga M, O’Cleirigh C, Safren S. Review of treatment studies of depression in HIV. Top HIV Med. 2006;14(3):112–24.PubMed

27.

Markowitz J, Rabkin J, Perry S. Treating depression in HIV-positive patients. AIDS. 1994;8(4):403–12.PubMedCrossRef

28.

Lee M, Cohen L, Hadley S, Goodwin F. Cognitive-behavioral group therapy with medication for depressed gay men with AIDS or symptomatic HIV infection. Psychiatr Serv. 1999;50(7):948–52.PubMed

29.

Markowitz J, Kocsis J, Fishman B, Spielman L, Jacobsberg L, Frances A, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry. 1998;55(5):452–7.PubMedCrossRef

30.

Kelly J, Murphy D, Bahr G, Kalichman S, Morgan M, Stevenson L, et al. Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry. 1993;150(11):1679–86.PubMed

31.

APA. Diagnostics and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 1994.

32.

Williams JW Jr, Noel PH, Cordes JA, Ramirez G, Pignone M. Is this patient clinically depressed? JAMA. 2002;287(9):1160–70.PubMedCrossRef

33.

Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450–60.PubMedCrossRef

34.

Olley BO, Seedat S, Nei DG, Stein DJ. Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. AIDS Patient Care STDS. 2004;18(8):481–7.PubMedCrossRef

35.

Hatzenbuehler ML, Nolen-Hoeksema S, Erickson SJ. Minority stress predictors of HIV risk behavior, substance use, and depressive symptoms: results from a prospective study of bereaved gay men. Health Psychol. 2008;27(4):455–62.PubMedCrossRef

36.

Monahan PO, Shacham E, Reece M, Kroenke K, Ong’or WO, Omollo O, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in Western Kenya. J Gen Intern Med. 2009;24(2):189–97.PubMedCrossRef

37.

Cockram A, Judd FK, Mijch A, Norman T. The evaluation of depression in inpatients with HIV disease. Aust N Z J Psychiatry. 1999;33(3):344–52.PubMedCrossRef

38.

Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662–70.PubMedCrossRef

39.

Voss J, Portillo CJ, Holzemer WL, Dodd MJ. Symptom cluster of fatigue and depression in HIV/AIDS. J Prev Interv Community. 2007;33(1–2):19–34.PubMedCrossRef

40.

Kearns NP, Cruickshank CA, McGuigan KJ, Riley SA, Shaw SP, Snaith RP. A comparison of depression rating scales. Br J Psychiatry. 1982;141:45–9.PubMedCrossRef

41.

Koenig HG, George LK, Peterson BL, Pieper CF. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry. 1997;154(10):1376–83.PubMed

42.

Koenig HG, Pappas P, Holsinger T, Bachar JR. Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? J Am Geriatr Soc. 1995;43(5):472–8.PubMed

43.

Rapp SR, Vrana S. Substituting nonsomatic for somatic symptoms in the diagnosis of depression in elderly male medical patients. Am J Psychiatry. 1989;146(9):1197–200.PubMed

44.

Kathol RG, Mutgi A, Williams J, Clamon G, Noyes R Jr. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry. 1990;147(8):1021–4.PubMed

45.

Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122(12):913–21.PubMed

46.

Maj M, Janssen R, Starace F, Zaudig M, Satz P, Sughondhabirom B, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry. 1994;51(1):39–49.PubMed

47.

Hirshfield S, Wolitski RJ, Chiasson MA, Remien RH, Humberstone M, Wong T. Screening for depressive symptoms in an online sample of men who have sex with men. AIDS Care. 2008;20(8):904–10.PubMedCrossRef

48.

Crane P, Gibbons L, Willig J, Mugavero M, Lawrence S, Schumacher J, et al. Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9). AIDS Care. 2010;22(7):874–5.PubMedCrossRef

49.

Kalichman SC, Weinhardt L. Negative affect and sexual risk behavior: comment on Crepaz and Marks (2001). Health Psychol. 2001;20(4):300–1.PubMedCrossRef

50.

Okawa J. Considerations for the cross-cultural evaluation of refugees and asylum seekers. In: Suzuki L, Ponterotto J, editors. Handbook of multicultural assessment: clinical psychological, and educational applications. San Francisco: Jossey-Bass; 2008. p. 165–94.

51.

Weiss MG, Kleinman A. Depression in cross-cultural perspective: developing a cultural informed model. Cross-cultural research and methodology series. Newbury Park, CA: Sage; 1988.

52.

Wierzbicka A. Emotion, language, and cultural scripts. Emotion and culture: empirical studies of mutual influence. Washington, DC: American Psychological Association; 1994.

53.

Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.PubMed

54.

Kazarian SS, Evans DR. Cultural clinical psychology. New York, NY: Oxford University Press, Inc.; 1998.

55.

WHO. Depressive disorders in different cultures: report of the WHO collaborative study of standardized assessment of depressive disorders. Geneva: World Health Organization; 1983.

56.

Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341(18):1329–35.PubMedCrossRef

57.

Kleinman AM. Depression, somatization and the “new cross-cultural psychiatry”. Soc Sci Med. 1977;11(1):3–10.PubMedCrossRef

58.

Jin H, Hampton Atkinson J, Yu X, Heaton RK, Shi C, Marcotte TP, et al. Depression and suicidality in HIV/AIDS in China. J Affect Disord. 2006;94(1–3):269–75.PubMedCrossRef

59.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.PubMed

60.

Weiss MG. Explanatory Model Interview Catalogue (EMIC): framework for comparative study of illness. Transcult Psychiatry. 1997;34:235–63.CrossRef

61.

Rao D, Young M, Raguram R. Culture, somatization and psychological distress: a study of symptom presentation in South Indian psychiatric patients from a public hospital. Psychopathology. 2007;40:349–55.PubMedCrossRef

62.

Raguram R, Weiss M, Keval H, Channabasavanna SM. Cultural dimensions of clinical depression in Bangalore, India. Anthropol Med. 2001;8:31–46.CrossRef

63.

Kim A, Lim EY. How critical is back translation in cross-cultural adaptation of attitude measures? Annual Meeting of the American Educational Research Association; April 19–23, 1999; Montreal, Quebec, Canada 1999.

64.

Napoles-Springer AM, Santoyo-Olsson J, O’Brien H, Stewart AL. Using cognitive interviews to develop surveys in diverse populations. Med Care. 2006;44(11 Suppl 3):S21–30.PubMedCrossRef

65.

Angel RJ. Narrative and the fundamental limitations of quantification in crosscultural research. Med Care. 2006;44(11 Suppl 3):S31–3.PubMedCrossRef

66.

Van de Vijver FJR, Leung K. Methods and data analysis of comparative research. In: Berry J, Poortinga Y, Pandey J, editors. Handbook of cross-cultural psychology, Volume 1: theory and method. Boston, MA: Allyn and Bacon; 1997.

67.

Carrico AW, Chesney MA, Johnson MO, Morin SF, Neilands TB, Remien RH, et al. Randomized controlled trial of a cognitive-behavioral intervention for HIV-positive persons: an investigation of treatment effects on psychosocial adjustment. AIDS Behav. 2009;13:555–63.PubMedCrossRef

68.

Safren SA, O’Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1–10.PubMedCrossRef

69.

Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74–81.PubMedCrossRef

70.

West SG, Duan N, Pequegnat W, Gaist P, Des Jarlais DC, Holtgrave D, et al. Alternatives to the randomized controlled trial. Am J Public Health. 2008;98(8):1359–66.PubMedCrossRef

71.

Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, et al. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry. 2001;50(10):792–801.PubMedCrossRef

72.

Collins LM, Murphy SA, Bierman KL. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5(3):185–96.PubMedCrossRef

73.

Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007;26:20–36.PubMedCrossRef

74.

Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–77.PubMed

75.

Orlando M, Burnam MA, Beckman R, Morton SC, London AS, Bing EG, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002;11(2):75–82.PubMedCrossRef

76.

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33; quiz 4-57.PubMed

77.

Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS. 2008;22(2):147–58.PubMedCrossRef

78.

Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008;38(1):43–51.PubMedCrossRef

79.

First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington: American Psychiatric Press, Inc.; 1996.

80.

Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med. 2006;7(2):112–21.PubMedCrossRef

81.

Stewart RC, Bunn J, Vokhiwa M, Umar E, Kauye F, Fitzgerald M, et al. Common mental disorder and associated factors amongst women with young infants in rural Malawi. Soc Psychiatry Psychiatr Epidemiol. 2010;45(5):551–9.PubMedCrossRef

82.

Mello VA, Malbergier A. Depression in women infected with HIV. Rev Bras Psiquiatr. 2006;28(1):10–7.PubMedCrossRef

83.

Lewis G, Pelosi AJ, Araya R, Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med. 1992;22(2):465–86.PubMedCrossRef

84.

Tostes MA, Chalub M, Botega NJ. The quality of life of HIV-infected women is associated with psychiatric morbidity. AIDS Care. 2004;16(2):177–86.PubMedCrossRef

85.

Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749–56.PubMedCrossRef

86.

Rogers G, Curry M, Oddy J, Pratt N, Beilby J, Wilkinson D. Depressive disorders and unprotected casual anal sex among Australian homosexually active men in primary care. HIV Med. 2003;4(3):271–5.PubMedCrossRef

87.

Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.PubMedCrossRef

88.

Crane PK, Gibbons LE, Willig JH, Mugavero MJ, Lawrence ST, Schumacher JE, et al. Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9). AIDS Care. 2010;22(7):874–85.PubMedCrossRef

89.

Rao D, Feldman B, Fredericksen R, Simoni J, Crane P, Kitahata M, et al. HIV-related stigma and depressive symptoms: underlying mechanisms impacting medication adherence among people with HIV. International Conference on HIV Treatment Adherence; May 23–25, 2010; Miami, Florida.

90.

Mao L, Kidd MR, Rogers G, Andrews G, Newman CE, Booth A, et al. Social factors associated with Major Depressive Disorder in homosexually active, gay men attending general practices in urban Australia. Aust N Z J Public Health. 2009;33(1):83–6.PubMedCrossRef

91.

Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–92.PubMedCrossRef

92.

Broadhead WE, Leon AC, Weissman MM, Barrett JE, Blacklow RS, Gilbert TT, et al. Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med. 1995;4(3):211–9.PubMedCrossRef

93.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRef

94.

Sahay S, Phadke M, Brahme R, Paralikar V, Joshi V, Sane S, et al. Correlates of anxiety and depression among HIV test-seekers at a Voluntary Counseling and Testing facility in Pune, India. Qual Life Res. 2007;16(1):41–52.PubMedCrossRef

95.

Hasanah CI, Zaliha AR, Mahiran M. Factors influencing the quality of life in patients with HIV in Malaysia. Qual Life Res. 26.

96.

Jayathunge MP, Bowanwatanuwong C, Maek AnW, Pitisuttithum BP. Psychosocial burden of abnormal pap smears among HIV-infected women at Chon Buri hospital, Thailand. Southeast Asian J Trop Med Public Health. 2010;41(1):224–34.PubMed

97.

Au A, Chan I, Li P, Chung R, Po LM, Yu P. Stress and health-related quality of life among HIV-infected persons in Hong Kong. AIDS Behav. 2004;8(2):119–29.PubMedCrossRef

98.

Beck AT. Beck depression inventory-II: Harcourt Brace and Company: The Psychological Corporation; 1996.

99.

Park J, Nachman S. The link between religion and HAART adherence in pediatric HIV patients. AIDS Care. 2010;15:1–6.

100.

Briongos Figuero LS, Bachiller Luque P, Palacios Martin T, Gonzalez Sagrado M, Eiros Bouza JM. Assessment of factors influencing health-related quality of life in HIV-infected patients. HIV Med. 17.

101.

Kagee A, Martin L. Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care. 2010;22(2):159–65.PubMedCrossRef

102.

Au A, Cheng C, Chan I, Leung P, Li P, Heaton RK. Subjective memory complaints, mood, and memory deficits among HIV/AIDS patients in Hong Kong. J Clin Exp Neuropsychol. 2008;30(3):338–48.PubMedCrossRef

103.

Kolaric B, Tesic V, Ivankovic D, Begovac J. Prevalence of moderate and severe depression among Croatian patients infected with human immunodeficiency virus. Coll Antropol. 2006;30(Suppl 2):85–8.PubMed

104.

Olley BO. Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: a controlled outcome study. AIDS Care. 2006;18(8):1025–31.PubMedCrossRef

105.

Pechansky F, von Diemen L, Kessler F, Hirakata V, Metzger D, Woody GE. Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil. J Urban Health. 2003;80(1):115–26.PubMed

106.

Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477–86.PubMedCrossRef

107.

Rush A, Trivedi M, Ibrahim H, Carmody T, Arnow B, Klein D, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.PubMedCrossRef

108.

Zimmerman M, Coryell W. The Inventory to Diagnose Depression (IDD): a self-report scale to diagnose major depressive disorder. J Consult Clin Psychol. 1987;55(1):55–9.PubMedCrossRef

109.

Komiti A, Judd F, Grech P, Mijch A, Hoy J, Williams B, et al. Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry. 2003;37(1):70–7.PubMedCrossRef

110.

Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med. 2003;33(2):351–6.PubMedCrossRef

111.

Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef

112.

Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50.PubMedCrossRef

113.

Safren SA, Thomas BE, Mimiaga MJ, Chandrasekaran V, Menon S, Swaminathan S, et al. Depressive symptoms and human immunodeficiency virus risk behavior among men who have sex with men in Chennai, India. Psychol Health Med. 2009;14(6):705–15.PubMedCrossRef

114.

Farley J, Miller E, Zamani A, Tepper V, Morris C, Oyegunle M, et al. Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence. J Int Assoc Physicians AIDS Care (Chic Ill). 2010;9(4):218–26.CrossRef

115.

Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10:44.PubMedCrossRef

116.

Cohen MH, Fabri M, Cai X, Shi Q, Hoover DR, Binagwaho A, et al. Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women. J Womens Health (Larchmt). 2009;18(11):1783–91.CrossRef

117.

Fincham D, Smit J, Carey P, Stein DJ, Seedat S. The relationship between behavioural inhibition, anxiety disorders, depression and CD4 counts in HIV-positive adults: a cross-sectional controlled study. AIDS Care. 2008;20(10):1279–83.PubMedCrossRef

118.

Hong Y, Li X, Fang X, Zhao R. Depressive symptoms and condom use with clients among female sex workers in China. Sex Health. 2007;4(2):99–104.PubMedCrossRef

119.

Poupard M, Ngom Gueye NF, Thiam D, Ndiaye B, Girard PM, Delaporte E, et al. Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal. HIV Med. 2007;8(2):92–5.PubMedCrossRef

120.

Watanabe M, Nishimura K, Inoue T, Kimura S, Oka S. A discriminative study of health-related quality of life assessment in HIV-1-infected persons living in Japan using the Multidimensional Quality of Life Questionnaire for persons with HIV/AIDS. Int J STD AIDS. 2004;15(2):107–15.PubMedCrossRef

121.

Eller LS, Mahat G. Psychological factors in Nepali former commercial sex workers with HIV. J Nurs Scholarsh. 2003;35(1):53–60.PubMedCrossRef

122.

Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health. 1993;5(2):179–93.PubMedCrossRef

123.

Santor DA, Coyen JC. Shortening the CES-D to improve its ability to detect cases of depression. Psychol Assess. 1997;9(3):233–43.CrossRef

124.

Turvey CL, Wallace RB, Herzog R. A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr. 1999;11(2):139–48.PubMedCrossRef

125.

Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry. 1974;7:79–110.PubMed

126.

Joseph JG, Caumartin SM, Tal M, Kirscht JP, Kessler RC, Ostrow DG, et al. Psychological functioning in a cohort of gay men at risk for AIDS. A three-year descriptive study. J Nerv Ment Dis. 1990;178(10):607–15.PubMedCrossRef

127.

Bolton P, Wilk CM, Ndogoni L. Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol. 2004;39(6):442–7.PubMedCrossRef

128.

Kaaya SF, Fawzi MC, Mbwambo JK, Lee B, Msamanga GI, Fawzi W. Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand. 2002;106(1):9–19.PubMedCrossRef

129.

Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacol Bull. 1973;9(1):13–28.PubMed

130.

Derogatis L. SCL-90-R: administration, scoring and procedures manual II for the revised version. Towson, MD: Clinical Psychometric Research; 1992.

131.

Hawkins T, Geist C, Young B, Giblin A, Mercier RC, Thornton K, et al. Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients. HIV Clin Trials. 2005;6(4):187–96.PubMedCrossRef

132.

Jin C, Zhao G, Zhang F, Feng L, Wu N. The psychological status of HIV-positive people and their psychosocial experiences in eastern China. HIV Med. 2010;11(4):253–9.PubMedCrossRef

133.

Alciati A, Starace F, Scaramelli B, Campaniello M, Adriani B, Mellado C, et al. Has there been a decrease in the prevalence of mood disorders in HIV-seropositive individuals since the introduction of combination therapy? Eur Psychiatry. 2001;16(8):491–6.PubMedCrossRef

134.

Goldberg D. The detection of psychiatric illness by questionnaire. London: Oxford University Press; 1972.

135.

Bernatsky S, Souza R, de Jong K. Mental health in HIV-positive pregnant women: results from Angola. AIDS Care. 2007;19(5):674–6.PubMedCrossRef

136.

Hamilton M. Comparative value of rating scales. Br J Clin Pharmacol. 1976;3(1 Suppl 1):58–60.PubMed

137.

Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–76.PubMedCrossRef

138.

Spies G, Kader K, Kidd M, Smit J, Myer L, Stein DJ, et al. Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care. 2009;21(9):1163–8.PubMedCrossRef

139.

Deribew A, Tesfaye M, Hailmichael Y, Negussu N, Daba S, Wogi A, et al. Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes. 2009;7:105.PubMedCrossRef

140.

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.PubMedCrossRef

141.

Carvalhal AS, de Abreu PB, Spode A, Correa J, Kapczinski F. An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry. 2003;64(4):421–4.PubMedCrossRef

142.

Sebit MB, Chandiwana SK, Latif AS, Gomo E, Acuda SW, Makoni F, et al. Neuropsychiatric aspects of HIV disease progression: impact of traditional herbs on adult patients in Zimbabwe. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(3):451–6.PubMedCrossRef

Titel: Challenges in Addressing Depression in HIV Research: Assessment, Cultural Context, and Methods
Publikationsdatum: 01.02.2011
Erschienen in: AIDS and Behavior / Ausgabe 2/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-010-9836-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Internet Use Among Female Sex Workers in China: Implications for HIV/STI Prevention

Psychometric Characteristics and Race-Related Measurement Invariance of Stress and Coping Measures in Adults With HIV/AIDS

Trends of HIV and Sexually Transmitted Infections, Estimated HIV Incidence, and Risky Sexual Behaviors Among Gay Bathhouse Attendees in Taiwan: 2004–2008

Intensive Case Management Before and After Prison Release is No More Effective Than Comprehensive Pre-Release Discharge Planning in Linking HIV-Infected Prisoners to Care: A Randomized Trial

Notes on the Frequency of Routinely Collected and Self-Reported Behavioral Data in HIV Prevention Trials